This is not the most recent version of the article. View current version (31 JAN 2013)

Intervention Protocol

Human chorionic gonadotrophin (hCG) for preventing miscarriage

  1. Lara C Morley2,
  2. Nigel Simpson3,
  3. Thomas Tang1,*

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 7 JUL 2010

DOI: 10.1002/14651858.CD008611


How to Cite

Morley LC, Simpson N, Tang T. Human chorionic gonadotrophin (hCG) for preventing miscarriage (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD008611. DOI: 10.1002/14651858.CD008611.

Author Information

  1. 1

    Bradford Teaching Hospitals NHS Trust, Obstetrics and Gynaecology, Bradford, UK

  2. 2

    Leeds University Medical School, Leeds, West Yorkshire, UK

  3. 3

    The General Infirmary of Leeds, Department of Obstetrics and Gynaecology, Leeds, West Yorkshire, UK

*Thomas Tang, Obstetrics and Gynaecology, Bradford Teaching Hospitals NHS Trust, Duckworth Lane, Bradford, BD9 6RJ, UK. t.m.h.tang@leeds.ac.uk. medtmht@leeds.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 JUL 2010

SEARCH

This is not the most recent version of the article. View current version (31 JAN 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of therapeutic or prophylactic hCG in women with a history of recurrent miscarriage or risk factors for pregnancy loss.